Cervical Stiffness Measured by the Cervisense Intravaginal Probe for Identification of Imminent Delivery in

Andrea Samper-Girona1,2, Amaia Aiartzaguena3, Jorge Burgos3

  • 1Hospital Universitario Clínico San Cecilio, 18016 Granada, Spain.

Background and Objectives: Risk stratification in symptomatic threatened preterm labor (TPTL) remains challenging, particularly for clinically actionable time horizons. We evaluated whether quantitative cervical stiffness measured with the Cervisense Intravaginal Probe discriminates between women who will and will not deliver within 7, 10, or 14 days after presentation and assessed its discriminative performance alone and in combination with transvaginal cervical length. Materials and Methods: We conducted a multicenter, non-interventional study across 10 obstetric emergency units in Spain. Eligible participants were women aged ≥ 18 years with a live singleton pregnancy at 28+0 to 36+6 weeks, regular uterine contractions, intact membranes, and cervical dilatation < 2 cm on speculum examination. Cervical stiffness was measured at presentation using torsional wave elastography with the Cervisense Intravaginal Probe. Cervical length was measured by transvaginal ultrasonography following international standards. Outcomes were delivery within 7, 10, and 14 days after presentation. Discrimination was quantified using the area under the receiver operating characteristic curve (AUC). An explanatory multivariable logistic regression model for delivery within 14 days included cervical stiffness, cervical length, and covariates selected as potential confounders. Results: Among 305 participants, 17 (5.6%) delivered within 7 days, 19 (6.2%) within 10 days, and 24 (7.9%) within 14 days. Mean cervical stiffness was lower among women who delivered within 14 days than among those who did not (8.63 vs. 14.82 kPa; p = 0.048). Cervical length was shorter among women who delivered within 7, 10, and 14 days (all p < 0.001). Discrimination for cervical stiffness was moderate (AUC, 0.66, 0.64, and 0.73 for ≤7, ≤10, and ≤14 days) and higher for cervical length (AUC, 0.80, 0.77, and 0.78). The combined model achieved the highest discrimination (AUC, 0.85, 0.85, and 0.86). In the ≤14-day explanatory model, higher log-transformed cervical stiffness was associated with lower odds of delivery (OR, 0.907; 95% CI, 0.828 to 0.995; p = 0.039), as was longer cervical length (OR per 1 mm, 0.910; 95% CI, 0.876 to 0.946; p < 0.001). Conclusions: In symptomatic TPTL, Cervisense-derived cervical stiffness showed moderate discrimination for short-term delivery and provided complementary information to cervical length, with improved discrimination when both measures were combined. These findings support future studies developing multivariable prediction models that incorporate quantitative cervical consistency.

Related Concept Videos

Uterus and Cervix01:18

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
Assessing Body Temperature - Rectal01:27

Assessing Body Temperature - Rectal

Rectal temperature measurement is considered the most precise method for assessing core body temperature and typically registers higher than oral temperature. For adults, the rectal thermometer should be inserted 1 to 1.5 inches into the rectum to obtain the most accurate reading.
Follow these steps for rectal temperature assessment:
Step 1: Perform hand hygiene and don clean gloves to prevent cross-infection.
Step 2: Position the patient in a side-lying position to better visualize the rectal...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...